UBS posts quarterly profit of $1.2bn and hikes its dividend by 22 per cent and reaffirms its forecasts for the year. The Swiss lender says it is on track to fully integrate Credit Suisse later this year but CEO Sergio Ermotti says clients remain wary due to geo-political considerations. Pharma giant Novo Nordisk sees U.S.-listed shares plunge after warning of disappointing sales due to competition to its flagship obesity drugs. CEO Mike Doustdar believes the GLP-1 market will only get bigger. And in tech news, Anthropic’s new ‘Claude’ model causes a wider sell-off in enterprise and cloud software as the threat of A.I. disruption looms over white-collar sectors.  

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.